KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $1.3 billion.

  • Bausch Health Companies' Cash & Current Investments rose 7866.67% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 7866.67%. This contributed to the annual value of $1.2 billion for FY2024, which is 2484.41% up from last year.
  • According to the latest figures from Q3 2025, Bausch Health Companies' Cash & Current Investments is $1.3 billion, which was up 7866.67% from $1.7 billion recorded in Q2 2025.
  • Bausch Health Companies' 5-year Cash & Current Investments high stood at $2.5 billion for Q1 2022, and its period low was $497.0 million during Q3 2022.
  • Its 5-year average for Cash & Current Investments is $1.2 billion, with a median of $962.0 million in 2023.
  • As far as peak fluctuations go, Bausch Health Companies' Cash & Current Investments crashed by 7841.46% in 2023, and later surged by 17977.53% in 2025.
  • Over the past 5 years, Bausch Health Companies' Cash & Current Investments (Quarter) stood at $582.0 million in 2021, then increased by 1.55% to $591.0 million in 2022, then surged by 62.77% to $962.0 million in 2023, then rose by 24.84% to $1.2 billion in 2024, then increased by 11.57% to $1.3 billion in 2025.
  • Its Cash & Current Investments was $1.3 billion in Q3 2025, compared to $1.7 billion in Q2 2025 and $1.2 billion in Q1 2025.